Silence Therapeutics (SLN) Retained Earnings: 2019-2024
Historic Retained Earnings for Silence Therapeutics (SLN) over the last 6 years, with Dec 2024 value amounting to -$474.0 million.
- Silence Therapeutics' Retained Earnings fell 22.29% to -$550.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$550.8 million, marking a year-over-year decrease of 22.29%. This contributed to the annual value of -$474.0 million for FY2024, which is 9.76% down from last year.
- According to the latest figures from FY2024, Silence Therapeutics' Retained Earnings is -$474.0 million, which was down 9.76% from -$431.9 million recorded in FY2023.
- In the past 5 years, Silence Therapeutics' Retained Earnings registered a high of -$236.6 million during FY2020, and its lowest value of -$474.0 million during FY2024.
- Over the past 3 years, Silence Therapeutics' median Retained Earnings value was -$431.9 million (recorded in 2023), while the average stood at -$410.6 million.
- In the last 5 years, Silence Therapeutics' Retained Earnings increased by 6.21% in 2022 and then plummeted by 32.56% in 2023.
- MRY analysis of 5 years shows Silence Therapeutics' Retained Earnings stood at -$236.6 million in 2020, then dropped by 29.68% to -$306.8 million in 2021, then fell by 6.21% to -$325.8 million in 2022, then tumbled by 32.56% to -$431.9 million in 2023, then dropped by 9.76% to -$474.0 million in 2024.
- Its last three reported values are -$474.0 million in FY2024, -$431.9 million for FY2023, and -$325.8 million during FY2022.